1977
DOI: 10.1016/0006-291x(77)91166-4
|View full text |Cite
|
Sign up to set email alerts
|

Phosgene: A metabolite of chloroform

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
50
0

Year Published

1993
1993
2009
2009

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 205 publications
(50 citation statements)
references
References 11 publications
0
50
0
Order By: Relevance
“…BDCM induces renal toxicity in rats and hepatic toxicity in mice (10)(11)(12). Both chemicals have been shown to be metabolized by cytochrome P450, although the active metabolite has only been identified for CHCl3 (13)(14)(15). BDCM (but not CHCl3) has been demonstrated to be mutagenic (16).…”
Section: Introductionmentioning
confidence: 99%
“…BDCM induces renal toxicity in rats and hepatic toxicity in mice (10)(11)(12). Both chemicals have been shown to be metabolized by cytochrome P450, although the active metabolite has only been identified for CHCl3 (13)(14)(15). BDCM (but not CHCl3) has been demonstrated to be mutagenic (16).…”
Section: Introductionmentioning
confidence: 99%
“…1). Extensive in vitro and in vivo studies on rodents have demonstrated that chloroform may be metabolized oxidatively to trichloromethanol, which spontaneously decomposes to the electrophilic phosgene (Mansuy et al, 1977;Pohl et al, 1977). COCl 2 is highly reactive and binds covalently to cell components containing nucleophilic groups, including proteins, phospholipid (PL) polar heads, and reduced glutathione (Pohl et al, 1981;Testai et al, 1990;De Biasi et al, 1992;Gemma et al, 1996;Vittozzi et al, 2000).…”
mentioning
confidence: 99%
“…1 mediated oxidation of APAP but also to its cytochrome P-450-independent deacetylation which is not responsible for APAP-induced nephrotoxicity in normal SD rats. In addition, since there were no differences in the severity of gentamicin- (Tarloff and Goldstein, 1994), chloroform- (Pohl et al, 1977;Kluwe and Hook, 1981), or 45 minischemia/reperfusion-induced renal lesions (Arnold et al, 1986;Shapiro et al, 1987Shapiro et al, , 1989Mourelle et al, 1991) between the non-pretreated and the fructose-pretreated rats (Ishida et al, 1997a), alterations in APAP-specific pharmacokinetics and metabolism may play an important role in enhancement of APAP nephrotoxicity in fructosepretreated rats.…”
Section: Effects Of Hypertriglyceridemia On Apap-induced Hepatorenal mentioning
confidence: 99%